ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

Converging Goals: Public Health & the Cancer Moonshot Initiative

September 22, 2022

On September 16, the National Comprehensive Cancer Network convened experts and stakeholders in D.C. for a policy summit spotlighting today’s cancer screening and prevention landscape. Learn what speakers discussed, including what changes need to happen to create an equitable future for all people at risk—or not—for cancer.

Converging Goals: Public Health & the Cancer Moonshot Initiative

This is the first post in a blog series on the National Comprehensive Cancer Network (NCCN) Policy Summit: Reducing the Cancer Burden through Prevention and Early Detection.

On September 16, the NCCN convened experts and stakeholders in D.C. for a policy summit spotlighting today’s cancer screening and prevention landscape, as speakers discussed what changes need to happen to create an equitable future for all people at risk—or not—for cancer. One such example of this future is the Cancer Moonshot Initiative and the work that is already being done to address inequities along the cancer care continuum.

For example, the Association of Cancer Care Centers (ACCC) launched the Appalachian Community Cancer Alliance in June. By partnering with several of its oncology state societies, ACCC seeks to provide residents of the Appalachian Region with interdisciplinary, patient-centered approaches to cancer care, beginning with prevention and throughout survivorship, with an emphasis on enhanced quality of life. The alliance’s goal is to develop proven, practical solutions for improving the entire cancer care continuum in Appalachia and all underserved areas of the United States. The alliance aligns seamlessly with the goals of the Cancer Moonshot and was featured by Danielle Carnival, PhD, White House Cancer Moonshot coordinator, as one example of the progress that is being made as part of President Biden’s promise to “end cancer as we know it.”

The Role of Public Health

Public health is another key aspect of the Cancer Moonshot Initiative and integral to any effort looking to achieve equity in healthcare. According to Lisa Richardson, MD, MPH, director of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention (CDC), public health offers support, especially in oncology/hematology, for mitigating disparities—it is the only disease that has federal legislation in place to require tracking and reporting of incidence, mortality, and more.

This immense amount of publicly available data can and should be used to identify and mitigate health disparities to improve the patient experience and outcomes. Dr. Richardson is advocating for a more streamlined system at the CDC that would allow all data to be publicly shared much faster than its current model allows. By sharing trends and findings early, CDC data can be better used for quality benchmarking and improvement initiatives at local, state, and national levels.

Just how do the CDC’s data and improvement efforts impact public health? Dr. Richardson shared that the agency’s efforts in increasing colorectal cancer screening is the best example of this work. The CDC utilized its Health Systems Change model in its Colorectal Cancer Control Program, emphasizing the use of multicomponent, evidence-based interventions to increase colorectal cancer screening among eligible adults. The program provided funding to applicable healthcare organizations to make changes at the system level, instilling an institutional change in thought: screening for colorectal cancer is not just a test; instead, it is a series of services that ends with no diagnosis or a confirmed diagnosis with treatment plans ready to be made.

Since the Colorectal Cancer Control Program’s inception in 2015, the CDC has reached 1.3 million patients (from just 50,000 patients) who qualify for colorectal cancer screening, working closely with more than 6,000 healthcare providers in about 800 clinics. The results: participating organizations that implemented 3 interventions saw a 12 percent increase and those that implemented 4 interventions saw a 33 percent increase in their colorectal cancer screening rate, which demonstrates an increase in providers’ use of multicomponent interventions to reach a confirmed diagnosis and improving colorectal cancer screening rates nationwide.

According to Dr. Richardson, CDC data and programs like the above offer support in identifying barriers to care, investigating and implementing solutions, and continuing to refine those solutions to ensure they are meeting the needs of every person entering the healthcare system. Additionally, the CDC is empowering scientists, getting accurate data from state health departments and health systems/hospitals, encouraging innovation, and promoting collaboration across organizations to improve public health in America. “If we don’t try, we’re never going to get there,” Dr. Richardson said, emphasizing that any public health efforts—whether on a local or national scale—should not be run by fear of failure. Instead, Dr. Richardson closed her keynote address by stating that it is important to fail, so you can learn from your experience, modify, and improve your solution(s)—a testament that can be applied to any cancer program or practice looking to mitigate the health disparities that impact their communities.

Bringing It All Together

Just before this summit, on September 12, President Biden visited the JFK Library in Boston to further discuss his vision for the Cancer Moonshot Initiative. This address was in commemoration of the 60th anniversary of President Kennedy’s Moonshot speech.

In his address, President Biden made 3 announcements:

  • The appointment of Dr. Renee Wegrzyn as the inaugural director of the Advanced Research Projects Agency for Health, a new agency to drive biomedical innovation that supports the health of all Americans
  • An executive order to launch the National Biotechnology and Biomanufacturing Initiative to ensure the U.S. continues to produce cutting-edge biotechnologies and other innovations
  • An update of the Cancer Cabinet’s progress toward delivering game-changing cancer detection technologies and supporting talented researchers from across the nation.

As these announcements show, the Cancer Moonshot demonstrates President Biden's personal commitment to identify cancer as a federal priority and ending the disease as we know it. This priority then helps agencies like the CDC continue and improve the work they are doing, while bringing together stakeholders like ACCC to collaborate and develop partnerships to effect positive change in cancer care delivery.

In closing her keynote address, Dr. Carnival stated: “We need to bring the cancer care system to patients.” Delivering on this sentiment is where public health and the Cancer Moonshot Initiative converge.


Related Content

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

A Leadership Playbook for Responsible AI AdoptionACCCBuzz Blog

A Leadership Playbook for Responsible AI Adoption

June 4, 2026

Health Literacy in the Digital Age: An NCCN Policy SummitACCCBuzz Blog

Health Literacy in the Digital Age: An NCCN Policy Summit

Gabrielle Stearns

June 2, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Each year, the NCCN State Oncology Society Forum is thoughtfully organized to foster meaningful collaboration and forge common bonds to advance dignity and fair access to cancer care. In this blog, Sean T. McCarson shares key insights from stakeholders across the oncology policy landscape at this year's meeting.

Highlights from Volume 41, Number 3 Oncology Issues

Highlights from Volume 41, Number 3 Oncology Issues

The latest issue of Oncology Issues features key insights from the inaugural ACCC Leadership Summit, strategies to adjust to rising patient volumes and workforce strain, advanced practice leadership models, and more.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

Data-Driven Toxicity Management for ADCs – [Video Podcast] Ep. 235

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login